Malaysian biotech firm banks $5.7m in series A round
Biogenes Technologies develops, produces, and markets synthetic antibody diagnostics products via its proprietary platform. The biotech firm is headquartered in Malaysia and plans to enter Indonesia and the Philippines this year.
Malaysian biotech firm banks $5.7m in series A round
Biogenes Technologies develops, produces, and markets synthetic antibody diagnostics products via its proprietary platform. The biotech firm is headquartered in Malaysia and plans to enter Indonesia and the Philippines this year.
Funding details
- Funding amount: $5,700,000
- Other investor: Pembangunan Ekuiti
- Stage: Series A
- Source
More details
Biogenes Technologies
|
